328 related articles for article (PubMed ID: 26408673)
1. Chronic Lymphocytic Leukemia: Current Concepts.
Yu EM; Kittai A; Tabbara IA
Anticancer Res; 2015 Oct; 35(10):5149-65. PubMed ID: 26408673
[TBL] [Abstract][Full Text] [Related]
2. Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.
Barrientos JC
Future Oncol; 2016 Sep; 12(18):2077-94. PubMed ID: 27324214
[TBL] [Abstract][Full Text] [Related]
3. The shrinking role of chemotherapy in the treatment of chronic lymphocytic leukemia.
Jacobs RW; Awan FT; Leslie LA; Usmani SZ; Ghosh N
Expert Rev Hematol; 2016 Dec; 9(12):1177-1187. PubMed ID: 27791448
[TBL] [Abstract][Full Text] [Related]
4. Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective.
Owen C; Assouline S; Kuruvilla J; Uchida C; Bellingham C; Sehn L
Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):627-634.e5. PubMed ID: 26416145
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.
Hallek M
Am J Hematol; 2015 May; 90(5):446-60. PubMed ID: 25908509
[TBL] [Abstract][Full Text] [Related]
6. Predictive and prognostic biomarkers in the era of new targeted therapies for chronic lymphocytic leukemia.
Rossi D; Gerber B; Stüssi G
Leuk Lymphoma; 2017 Jul; 58(7):1548-1560. PubMed ID: 27808579
[TBL] [Abstract][Full Text] [Related]
7. A review of pharmacologic options for previously untreated chronic lymphocytic leukemia.
Wilhelm K; Yang D
J Oncol Pharm Pract; 2011 Jun; 17(2):91-103. PubMed ID: 20085962
[TBL] [Abstract][Full Text] [Related]
8. Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies.
Hallek M
Hematology Am Soc Hematol Educ Program; 2013; 2013():138-50. PubMed ID: 24319175
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemia: a clinical review including Korean cohorts.
Jeon YW; Cho SG
Korean J Intern Med; 2016 May; 31(3):433-43. PubMed ID: 27044858
[TBL] [Abstract][Full Text] [Related]
10. How I treat chronic lymphocytic leukemia in older patients.
Heraly B; Morrison VA
J Geriatr Oncol; 2015 Sep; 6(5):333-40. PubMed ID: 26343987
[TBL] [Abstract][Full Text] [Related]
11. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
12. Resistance Mechanisms to Targeted Agents in Chronic Lymphocytic Leukemia.
Kittai AS; Woyach JA
Cancer J; 2019; 25(6):428-435. PubMed ID: 31764124
[TBL] [Abstract][Full Text] [Related]
13. [Chronic lymphocytic leukemia].
Aoki S
Rinsho Ketsueki; 2016 Mar; 57(3):238-48. PubMed ID: 27076234
[TBL] [Abstract][Full Text] [Related]
14. Beyond detectable minimal residual disease in chronic lymphocytic leukemia.
Hillmen P
Semin Oncol; 2006 Apr; 33(2 Suppl 5):S23-8. PubMed ID: 16720200
[TBL] [Abstract][Full Text] [Related]
15. Update on signal inhibitors in chronic lymphocytic leukemia.
Boddu P; Jain N
Clin Adv Hematol Oncol; 2018 Apr; 16(4):279-288. PubMed ID: 29742083
[TBL] [Abstract][Full Text] [Related]
16. Novel agents in chronic lymphocytic leukemia: efficacy and tolerability of new therapies.
Lin TS
Clin Lymphoma Myeloma; 2008 Aug; 8 Suppl 4():S137-43. PubMed ID: 18952544
[TBL] [Abstract][Full Text] [Related]
17. Management of Chronic Lymphocytic Leukemia in the Elderly.
Barrientos JC
Cancer Control; 2015 Oct; 22(4 Suppl):17-23. PubMed ID: 26618342
[TBL] [Abstract][Full Text] [Related]
18. How to Choose the Best Treatment and Testing for Chronic Lymphocytic Leukemia in the Tsunami of New Treatment Options.
Yeung CCS; Shadman M
Curr Oncol Rep; 2019 Jul; 21(8):74. PubMed ID: 31327069
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapy for chronic lymphocytic leukemia: current status and future directions.
Arnason JE; Brown JR
Drugs; 2015 Feb; 75(2):143-55. PubMed ID: 25619739
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections.
Hilal T; Gea-Banacloche JC; Leis JF
Blood Rev; 2018 Sep; 32(5):387-399. PubMed ID: 29571669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
